Variant report
Variant | nsv582062 |
---|---|
Chromosome Location | chr2:57114156-57175087 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:57140755..57141275-chr7:78397919..78398439,2 | MCF-7 | breast: | |
2 | chr2:57035108..57036803-chr2:57124744..57126282,2 | K562 | blood: | |
3 | chr2:57125151..57127960-chr2:57127962..57130049,3 | K562 | blood: | |
4 | chr2:57125151..57127960-chr2:57127962..57130049,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570945690 | chr2:57132808-57132809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564075924 | chr2:57132813-57132814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112075193 | chr2:57132835-57132836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577889164 | chr2:57132880-57132881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188587060 | chr2:57132937-57132938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560100112 | chr2:57132999-57133000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115667443 | chr2:57133028-57133029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562560883 | chr2:57133031-57133032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs13409200 | chr2:57133037-57133038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148367590 | chr2:57133185-57133186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543915690 | chr2:57133187-57133188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540180498 | chr2:57133188-57133189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562713817 | chr2:57145843-57145844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10209765 | chr2:57145856-57145857 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs545478847 | chr2:57145870-57145871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62164124 | chr2:57145892-57145893 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs534059517 | chr2:57145932-57145933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527481035 | chr2:57145940-57145941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547741823 | chr2:57145968-57145969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185682469 | chr2:57146035-57146036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529911120 | chr2:57146070-57146071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553524838 | chr2:57146078-57146079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549768984 | chr2:57146089-57146090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144233680 | chr2:57146112-57146113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563312367 | chr2:57146121-57146122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7558725 | chr2:57146128-57146129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7585656 | chr2:57146129-57146130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7558729 | chr2:57146138-57146139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538355145 | chr2:57146154-57146155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183694686 | chr2:57161642-57161643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs578023333 | chr2:57161643-57161644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188273533 | chr2:57161660-57161661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560347700 | chr2:57161675-57161676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145465256 | chr2:57161684-57161685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542939546 | chr2:57161705-57161706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562531343 | chr2:57161740-57161741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370629851 | chr2:57161753-57161754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551329632 | chr2:57161894-57161895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571259432 | chr2:57161895-57161896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556780337 | chr2:57161922-57161923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538748446 | chr2:57161987-57161988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2865263 | chr2:57162041-57162042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372826947 | chr2:57162100-57162101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535776720 | chr2:57162117-57162118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549398683 | chr2:57162156-57162157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569497103 | chr2:57162184-57162185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115749821 | chr2:57162224-57162225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2865264 | chr2:57162234-57162235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558083914 | chr2:57162242-57162243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545549684 | chr2:57162243-57162244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57132800-57133200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:57132800-57133200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr2:57145800-57146200 | Enhancers | Aorta | Aorta |
4 | chr2:57161600-57162600 | Enhancers | Fetal Brain Female | brain |
5 | chr2:57162400-57162600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:57164400-57165000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:57164400-57165000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:57164400-57165000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:57165600-57166000 | Enhancers | Fetal Brain Male | brain |
10 | chr2:57166800-57167000 | Enhancers | HUES64 Cell Line | embryonic stem cell |